Monkeypox

Bavarian Nordic A/S (OTC: BVNRY) said it was making "every effort" to meet the high demand for its monkeypox vaccine worldwide as it kept its business outlook for the year. The Danish biotech's CEO said the outbreak was "unprecedented" in its first-half results....

The U.K.-based Oxford University researchers behind the COVID-19 treatment trial RECOVERY are back again, this time for a randomized controlled trial assessing SIGA Technologies Inc's (NASDAQ: SIGA) smallpox treatment Tpoxx (tecovirimat) for monkeypox. The National...

The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply. According to Reuters' tally, 1.5 million vials of Bavarian Nordic's monkeypox vaccine are either administered or currently available. Most doses are in the U.S., highlighting the...

Applied DNA Sciences Inc (NASDAQ: APDN) has submitted to the New York State Department of Health (NYSDOH) a validation package for its monkeypox virus test in support of a request for full approval as a form of NYSDOH Laboratory Developed Test (LDT).  The PCR-based diagnostic...

Bavarian Nordic A/S (OTC: BVNRY) signed up a U.S.-based manufacturer to fill and finish its Jynneos monkeypox vaccine, and the production is expected to begin later this year. The company aims to finish the technology transfer in three months to Grand River Aseptic Manufacturing (...

Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments. HHS Secretary Xavier Becerra, White House monkeypox response coordinator Bob Fenton and CDC director Dr. Rochelle Walensky will...

Blue Water Vaccines Inc (NASDAQ: BWV) plans to explore the potential to develop a novel monkeypox vaccine using its norovirus shell and protrusion (S&P) virus-like particle (VLP) platform. The company's S&P platform is currently being utilized to develop vaccine...

Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide, Bloomberg reported. The company is now exploring the possibility of outsourcing some of the production to...

Chembio Diagnostics Inc (NASDAQ: CEMI) is evaluating the potential to develop a monkeypox rapid point-of-care (POC) test.  Chembio is exploring the technical requirements for test development leveraging its multiple technology platforms, DPP, SURE CHECK, and STAT PAK, along...

Qiagen NV (NYSE: QGEN) launched the QIAstat-Dx Viral Vesicular Panel RUO, the first syndromic test to differentiate between monkeypox and five other pathogens which cause similar symptoms. The new panel ­– currently for research use only (RUO) – comes in cartridge...

Pasithea Therapeutics Corp (NASDAQ: KTTA) has announced results from a preliminary preclinical proof of concept study of PAS002, its tolerizing vaccine for multiple sclerosis (MS). PAS002 vaccine construct encodes GlialCAM, a molecule found in the brain's white matter that is attacked in...

Aethlon Medical Inc (NASDAQ: AEMD) said it is commissioning a new in vitro binding experiment to confirm that the Hemopurifier effectively captures the current strain of the monkeypox virus. The Hemopurifier is an extracorporeal (i.e., outside of the body) blood filtration...

A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses has been approved by the Food and Drug Administration. What Happened: CNBC reports that the FDA authorized a new technique of administering Bavarian Nordic A/S’s (OTC: BVNRY) monkeypox...

Applied DNA Sciences Inc (NASDAQ: APDN) has initiated analytical validation of a company-developed, PCR-based monkeypox virus test specific to the genetic signature of the monkeypox virus.  The test has been developed as an NYSDOH Laboratory Developed Test (LDT) type.  If...

The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care and biotech stocks on the move. The Numbers: At this point, there are about 5,000...